Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Summary Antibiotics induce changes or dysbiosis of the intestinal microbiome. These antibiotic-induce changes may contribute to the pathogenesis of necrotizing enterocolitis (NEC) and antibiotic-associated diarrhea (AAD). Studies are beginning to unravel the contribution of specific groups of microbes to these diseases—most notably Gammaproteobacteria for NEC and bile acid- and carbohydrate-metabolizing microbes for AAD. Antibiotic-associated diarrhea occurs when antibiotic treatment induces diarrhea by altering the metabolic function of the patient’s intestinal microbiota leading to either an osmotic or infectious diarrhea, most notably Clostridium difficile infection (CDI). Antibiotic therapy impairs the host microbiota’s ability to resist colonization or expansion of pathogenic bacteria. In the case of CDI, there is growing evidence that microbiota-mediated bile acid metabolism is critical in the pathogenesis of this infection. Probiotics or other microbiota-targeted therapies may provide effective strategies to prevent and treat NEC and AAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Development of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
The Placenta Harbors a Unique Microbiome
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008599 · Cited by 2,494
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Neu, J., & Walker, W. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1005408 · Cited by 2,141
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Antibiotics, birth mode, and diet shape microbiome maturation during early life
Bokulich, N. A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., D. Lieber, A., Wu, F., Perez-Perez, G. I., Chen, Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7121 · Cited by 1,469
The Application of Ecological Theory Toward an Understanding of the Human Microbiome
Costello, E. K., Stagaman, K., Dethlefsen, L., Bohannan, B. J. M., & Relman, D. A. (2012) · Science · doi:10.1126/science.1224203 · Cited by 1,437
The maternal microbiota drives early postnatal innate immune development
Gomez de Agüero, M., Ganal-Vonarburg, S. C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., Steinert, A., Heikenwalder, M., Hapfelmeier, S., Sauer, U., et al. (2016) · Science · doi:10.1126/science.aad2571 · Cited by 1,231
Research works printed but not linked: 72
- Chai, 2012, Trends of outpatient prescription drug utilization in US children, 2002-2010, Pediatrics, 130, 23, 10.1542/peds.2011-2879 · DOI · Paper page
- Hicks, 2015, US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011, Clin Infect Dis, 60, 1308, 10.1093/cid/civ076 · DOI · Paper page
- Robinson, 2010, Antibiotic administration alters the community structure of the gastrointestinal microbiota, Gut Microbes, 1, 279, 10.4161/gmic.1.4.12614 · DOI · Paper page
- Giuliano, 1987, Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans, Antimicrob Agents Chemother, 31, 202, 10.1128/AAC.31.2.202 · DOI · Paper page
- Stappenbeck, 2002, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells, Proc Natl Acad Sci U S A, 99, 15451, 10.1073/pnas.202604299 · DOI · Paper page
- Joly, 2009, Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome, Am J Physiol Gastrointest Liver Physiol, 297, G116, 10.1152/ajpgi.90657.2008 · DOI
- Turnbaugh, 2007, The human microbiome project, Nature, 449, 804, 10.1038/nature06244 · DOI · Paper page
- Groer, 2014, Development of the preterm infant gut microbiome: a research priority, Microbiome, 2, 38, 10.1186/2049-2618-2-38 · DOI · Paper page
- Fujimura, 2010, Role of the gut microbiota in defining human health, Expert Rev Anti Infect Ther, 8, 435, 10.1586/eri.10.14 · DOI · Paper page
- Stout, 2013, Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations, Am J Obstet Gynecol, 208, 226.e1-7, 10.1016/j.ajog.2013.01.018 · DOI · Paper page
- Satokari, 2009, Bifidobacterium and Lactobacillus DNA in the human placenta, Lett Appl Microbiol, 48, 8, 10.1111/j.1472-765X.2008.02475.x · DOI · Paper page
- Lauder, 2016, Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota, Microbiome, 4, 29, 10.1186/s40168-016-0172-3 · DOI · Paper page
- Yatsunenko, 2012, Human gut microbiome viewed across age and geography, Nature, 486, 222, 10.1038/nature11053 · DOI · Paper page
- Mueller, 2015, Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity, Int J Obes, 39, 665, 10.1038/ijo.2014.180 · DOI · Paper page
- Metsala, 2015, Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood, Clin Exp Allergy, 45, 137, 10.1111/cea.12356 · DOI · Paper page
- Madan, 2016, Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants, JAMA Pediatr, 170, 212, 10.1001/jamapediatrics.2015.3732 · DOI · Paper page
- Neu, 2011, Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis, Clin Perinatol, 38, 321, 10.1016/j.clp.2011.03.008 · DOI · Paper page
- Renz-Polster, 2005, Caesarean section delivery and the risk of allergic disorders in childhood, Clin Exp Allergy, 35, 1466, 10.1111/j.1365-2222.2005.02356.x · DOI · Paper page
- Decker, 2010, Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children, Pediatrics, 125, e1433, 10.1542/peds.2009-2260 · DOI · Paper page
- Fernandez, 2013, The human milk microbiota: origin and potential roles in health and disease, Pharmacol Res, 69, 1, 10.1016/j.phrs.2012.09.001 · DOI · Paper page
- Azad, 2013, Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months, CMAJ, 185, 385, 10.1503/cmaj.121189 · DOI · Paper page
- Bezirtzoglou, 2011, Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH), Anaerobe, 17, 478, 10.1016/j.anaerobe.2011.03.009 · DOI · Paper page
- Fouhy, 2012, High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin, Antimicrob Agents Chemother, 56, 5811, 10.1128/AAC.00789-12 · DOI · Paper page
- Mai, 2011, Fecal microbiota in premature infants prior to necrotizing enterocolitis, PLoS One, 6, e20647, 10.1371/journal.pone.0020647 · DOI · Paper page
- Morowitz, 2011, Strain-resolved community genomic analysis of gut microbial colonization in a premature infant, Proc Natl Acad Sci U S A, 108, 1128, 10.1073/pnas.1010992108 · DOI · Paper page
- Moles, 2013, Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life, PLoS One, 8, e66986, 10.1371/journal.pone.0066986 · DOI · Paper page
- Claud, 2013, Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants, Microbiome, 1, 20, 10.1186/2049-2618-1-20 · DOI · Paper page
- Yee, 2012, Incidence and timing of presentation of necrotizing enterocolitis in preterm infants, Pediatrics, 129, e298, 10.1542/peds.2011-2022 · DOI · Paper page
- Afrazi, 2011, New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond, Pediatr Res, 69, 183, 10.1203/PDR.0b013e3182093280 · DOI
- Raveh-Sadka, 2015, Gut bacteria are rarely shared by co-hospitalized premature infants, regardless of necrotizing enterocolitis development, Elife, 4, 10.7554/eLife.05477 · DOI · Paper page
- Normann, 2013, Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis, Acta Paediatr, 102, 129, 10.1111/apa.12059 · DOI · Paper page
- Torrazza, 2013, Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis, PLoS One, 8, e83304, 10.1371/journal.pone.0083304 · DOI · Paper page
- Morrow, 2013, Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants, Microbiome, 1, 13, 10.1186/2049-2618-1-13 · DOI · Paper page
- Zhou, 2015, Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study, PLoS One, 10, e0118632, 10.1371/journal.pone.0118632 · DOI · Paper page
- Heida, 2016, A necrotizing enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study, Clin Infect Dis, 62, 863, 10.1093/cid/ciw016 · DOI · Paper page
- Warner, 2016, Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study, Lancet, 387, 1928, 10.1016/S0140-6736(16)00081-7 · DOI · Paper page
- Siu, 1998, Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants, Arch Dis Child Fetal Neonatal Ed, 79, F105, 10.1136/fn.79.2.F105 · doi:10.1136/fn.79.2.f105
- Grylack, 1978, Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial, Am J Dis Child, 132, 1192, 10.1001/archpedi.1978.02120370040010 · DOI
- Boyle, 1978, Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis, J Pediatr, 93, 857, 10.1016/S0022-3476(78)81101-9 · doi:10.1016/s0022-3476(78)81101-9
- Egan, 1976, A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis, J Pediatr, 89, 467, 10.1016/S0022-3476(76)80553-7 · DOI
- Rowley, 1978, Gentamicin in prophylaxis of neonatal necrotising enterocolitis, Lancet, 2, 532, 10.1016/S0140-6736(78)92265-1 · doi:10.1016/s0140-6736(78)92265-1
- Bury, 2001, Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants, Cochrane Database Syst Rev, CD000405
- Haque, 2016, Necrotizing enterocolitis - some things old and some things new: a comprehensive review, J Clin Neonatol, 5
- Weintraub, 2012, Antenatal antibiotic exposure in preterm infants with necrotizing enterocolitis, J Perinatol, 32, 705, 10.1038/jp.2011.180 · doi:10.1038/jp.2011.180
- Cotten, 2009, Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants, Pediatrics, 123, 58, 10.1542/peds.2007-3423 · DOI · Paper page
- Abdel Ghany, 2012, Empirical antibiotic treatment and the risk of necrotizing enterocolitis and death in very low birth weight neonates, Ann Saudi Med, 32, 521, 10.5144/0256-4947.2012.521 · doi:10.5144/0256-4947.2012.521
- Kuppala, 2011, Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants, J Pediatr, 159, 720, 10.1016/j.jpeds.2011.05.033 · DOI · Paper page
- Alexander, 2011, Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis, J Pediatr, 159, 392, 10.1016/j.jpeds.2011.02.035 · DOI · Paper page
- Lau, 2015, Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis, J Pediatr Surg, 50, 1405, 10.1016/j.jpedsurg.2015.05.008 · DOI
- Bartlett, 2002, Clinical practice. Antibiotic-associated diarrhea, N Engl J Med, 346, 334, 10.1056/NEJMcp011603 · DOI · Paper page
- Kuehn, 2015, Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials, J Pediatr Pharmacol Ther, 20, 90
- Tedesco, 1974, Clindamycin-associated colitis. A prospective study, Ann Intern Med, 81, 429, 10.7326/0003-4819-81-4-429 · DOI · Paper page
- Bartlett, 2009, Clostridium difficile infection: historic review, Anaerobe, 15, 227, 10.1016/j.anaerobe.2009.09.004 · DOI
- Vincent, 2015, Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection, Antibiotics (Basel), 4, 230, 10.3390/antibiotics4030230 · DOI
- Larcombe, 2016, Involvement of bacteria other than Clostridium difficile in antibiotic-associated diarrhoea, Trends Microbiol, 24, 463, 10.1016/j.tim.2016.02.001 · DOI
- Peeters, 1989, Erythromycin is a motilin receptor agonist, Am J Physiol, 257, G470
- Clausen, 1991, Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea, Gastroenterology, 101, 1497, 10.1016/0016-5085(91)90384-W · DOI · Paper page
- Young, 2004, Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota, J Clin Microbiol, 42, 1203, 10.1128/JCM.42.3.1203-1206.2004 · DOI · Paper page
- Vrieze, 2014, Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity, J Hepatol, 60, 824, 10.1016/j.jhep.2013.11.034 · DOI · Paper page
- Mellon, 2000, Effect of oral antibiotics on intestinal production of propionic acid, Arch Dis Child, 82, 169, 10.1136/adc.82.2.169 · DOI · Paper page
- Theriot, 2015, Interactions between the gastrointestinal microbiome and Clostridium difficile, Annu Rev Microbiol, 69, 445, 10.1146/annurev-micro-091014-104115 · DOI · Paper page
- Wilson, 1983, Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination, J Clin Microbiol, 18, 1017, 10.1128/JCM.18.4.1017-1019.1983 · DOI · Paper page
- Cohen, 2010, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infect Control Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
- Kaleko, 2016, Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection, Anaerobe, 41, 58, 10.1016/j.anaerobe.2016.05.015 · DOI
- Vincent, 2013, Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection, Microbiome, 1, 18, 10.1186/2049-2618-1-18 · DOI · Paper page
- Hempel, 2011, Safety of probiotics to reduce risk and prevent or treat disease, Evid Rep Technol Assess (Full Rep), 1
- Parkes, 2009, The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea, Lancet Infect Dis, 9, 237, 10.1016/S1473-3099(09)70059-3 · DOI
- Goldenberg, 2015, Probiotics for the prevention of pediatric antibiotic-associated diarrhea, Cochrane Database Syst Rev, 10.1002/14651858.CD004827.pub4 · DOI · Paper page
- Allen, 2013, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 382, 1249, 10.1016/S0140-6736(13)61218-0 · DOI · Paper page
- Ehrhardt, 2016, Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial, Open Forum Infect Dis, 3, ofw011, 10.1093/ofid/ofw011 · DOI · Paper page
- Borriello, 2003, Safety of probiotics that contain lactobacilli or bifidobacteria, Clin Infect Dis, 36, 775, 10.1086/368080 · DOI · Paper page
- Degnan, 2008, The US Food and Drug Administration and probiotics: regulatory categorization, Clin Infect Dis, 46, S133, 10.1086/523324 · DOI · Paper page
Cited by
An update on the human and animal enteric pathogen Clostridium perfringens
Kiu, R., & Hall, L. J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0144-8 · Cited by 445
Shi, Z., Mehrotra, A., Gidengil, C. A., Poon, S. J., Uscher-Pines, L., & Ray, K. N. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.05091 · Cited by 108
Eichinger, A., Hagen, A., Meyer-Bühn, M., & Huebner, J. (2019) · Infection · doi:10.1007/s15010-018-1212-7 · Cited by 60
Ma, Z.-J., Wang, H.-J., Ma, X.-J., Li, Y., Yang, H.-J., Li, H., Su, J.-R., Zhang, C.-E., & Huang, L.-Q. (2020) · Food & Function · doi:10.1039/d0fo01536a · Cited by 62
Hagen, A., Eichinger, A., Meyer-Buehn, M., Schober, T., & Huebner, J. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1944-2 · Cited by 41
Rana, A., & Smriti (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70275 · Cited by 7
Metadata
- Authors
- Silverman, M. A., Konnikova, L., & Gerber, J. S.
- Venue
- Gastroenterology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 46
- Issue
- 1
- Pages
- 61-76
- ISSN
- 0889-8553 (ISSN-L)
- OpenAlex
- W2584698034
- Cited by
- 110
- References
- 28
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.